top of page

Home
All News
Members
More

Use tab to navigate through the menu items.

News

Trials

Cases

All Posts
Guidelines
Clinical Trials
Patient Stories & PEL
Case Reports
New Approvals
Spotlight

Cardiovascular outcomes with Semaglutide in high-risk patients

Cardiovascular outcomes with Semaglutide in high-risk patients

Cardiovascular outcomes with Semaglutide in high-risk patients

Oral Semaglutide was approved by the FDA in September 2019 to improve blood glucose control in adult patients with type 2 diabetes (1). ...

Ms. Roma Joglekar

Sep 9, 20252 min read

Subscribe to Our Newsletter

Join our mailing list

Email*

I want to subscribe to your mailing list.

Home
All News
Members

© 2025 RxNews. All Right Reserved.

bottom of page